GlassScriptPhysician profile
Gregory P Henderson
NPI 1619109519
$3,739.89
in general payments reported to CMS, 2019-2025
22 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $228 · 2021: $284 · 2022: $515 · 2023: $947 · 2024: $1,073 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,272 · Education: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,271.83 |
| Education | $260.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $897.41 | 2020-2025 | |
| Janssen Biotech, INC. | $621.54 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Amgen INC. | $348.34 | 2021-2024 | Otezla |
| Genzyme Corporation | $228.25 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $221.09 | 2022-2025 | Libtayo, Dupixent |
| Lilly USA, LLC | $176.51 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Genentech USA, INC. | $144.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $139.13 | 2020-2022 | |
| Galderma Laboratories, L.P. | $133.41 | 2021-2025 | Nemluvio, Aklief |
| Pfizer INC. | $124.48 | 2020-2023 | |
| Ucb, INC. | $107.17 | 2019-2025 | Bimzelx |
| Incyte Corporation | $105.01 | 2022-2024 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $90.76 | 2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $72.62 | 2024 | Zoryve |
| Strata Skin Sciences, INC. | $71.83 | 2024 | Xtrac |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $60.96 | 2023-2025 | Adbry, Anzupgo |
| Almirall LLC | $55.30 | 2025 | Klisyri |
| Bioventus LLC | $41.05 | 2022 | |
| Mimedx Group, INC. | $34.29 | 2024 | |
| Organon LLC | $24.15 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.29 | 2020 | |
| Smith+Nephew, INC. | $20.99 | 2024 | Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.